Advertisement

Topics

FDA Reversal Puts Alkermes Depression Drug Back On Track For January Approval

18:03 EDT 16 Apr 2018 | SCRIP

Reversing an earlier decision, FDA accepted Alkermes' new drug application (NDA) for ALKS 5461 for review, with a target action...

      

Related Stories

 

Original Article: FDA Reversal Puts Alkermes Depression Drug Back On Track For January Approval

NEXT ARTICLE

More From BioPortfolio on "FDA Reversal Puts Alkermes Depression Drug Back On Track For January Approval"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...